Mavoglurant (AFQ056) is an experimental drug candidate for the treatment of fragile X syndrome.It exerts its effect as an antagonist of the metabotropic glutamate receptor 5 (mGLU5).
Molecular Weight:
313.3908
Purity:
>98%
CAS Number:
[543906-09-8]
Formula:
C19NO3H23
Chemical structure of Mavoglurant (AFQ 056)
* VAT and and shipping costs not included. Errors and price changes excepted
